HORIZON TECHNOLOGY FINANCE C (HRZN) Fundamental Analysis & Valuation

NASDAQ:HRZNUS44045A1025

Current stock price

3.88 USD
-0.15 (-3.72%)
At close:
3.94 USD
+0.06 (+1.55%)
After Hours:

This HRZN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HRZN Profitability Analysis

1.1 Basic Checks

  • HRZN had positive earnings in the past year.
  • In the past year HRZN had a positive cash flow from operations.
  • In multiple years HRZN reported negative net income over the last 5 years.
  • In multiple years HRZN reported negative operating cash flow during the last 5 years.
HRZN Yearly Net Income VS EBIT VS OCF VS FCFHRZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • HRZN's Return On Assets of -0.33% is on the low side compared to the rest of the industry. HRZN is outperformed by 74.17% of its industry peers.
  • HRZN has a worse Return On Equity (-0.84%) than 69.17% of its industry peers.
  • With a Return On Invested Capital value of 0.14%, HRZN is not doing good in the industry: 75.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.33%
ROE -0.84%
ROIC 0.14%
ROA(3y)-1.05%
ROA(5y)1%
ROE(3y)-2.61%
ROE(5y)2.03%
ROIC(3y)N/A
ROIC(5y)N/A
HRZN Yearly ROA, ROE, ROICHRZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • With a Operating Margin value of 2.37%, HRZN is not doing good in the industry: 75.42% of the companies in the same industry are doing better.
  • HRZN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of HRZN (6.12%) is worse than 68.33% of its industry peers.
  • In the last couple of years the Gross Margin of HRZN has declined.
Industry RankSector Rank
OM 2.37%
PM (TTM) N/A
GM 6.12%
OM growth 3Y-58.91%
OM growth 5Y-35.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.81%
GM growth 5Y-24.29%
HRZN Yearly Profit, Operating, Gross MarginsHRZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

3

2. HRZN Health Analysis

2.1 Basic Checks

  • HRZN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HRZN has been increased compared to 5 years ago.
  • The debt/assets ratio for HRZN is higher compared to a year ago.
HRZN Yearly Shares OutstandingHRZN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
HRZN Yearly Total Debt VS Total AssetsHRZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -0.07, we must say that HRZN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of HRZN (-0.07) is worse than 78.75% of its industry peers.
  • HRZN has a debt to FCF ratio of 8.35. This is a slightly negative value and a sign of low solvency as HRZN would need 8.35 years to pay back of all of its debts.
  • HRZN has a better Debt to FCF ratio (8.35) than 61.67% of its industry peers.
  • A Debt/Equity ratio of 1.19 is on the high side and indicates that HRZN has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.19, HRZN is in line with its industry, outperforming 42.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 8.35
Altman-Z -0.07
ROIC/WACCN/A
WACCN/A
HRZN Yearly LT Debt VS Equity VS FCFHRZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that HRZN should not have too much problems paying its short term obligations.
  • HRZN has a Current ratio (1.33) which is in line with its industry peers.
  • HRZN has a Quick Ratio of 1.33. This is a normal value and indicates that HRZN is financially healthy and should not expect problems in meeting its short term obligations.
  • HRZN has a Quick ratio (1.33) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
HRZN Yearly Current Assets VS Current LiabilitesHRZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2

3. HRZN Growth Analysis

3.1 Past

  • HRZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.80%.
  • HRZN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.98% yearly.
  • The Revenue has grown by 11.33% in the past year. This is quite good.
  • The Revenue has been growing by 10.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-21.8%
EPS 3Y-10.28%
EPS 5Y-2.98%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-6.9%
Revenue growth 5Y10.34%
Sales Q2Q%-12.23%

3.2 Future

  • The Earnings Per Share is expected to decrease by -12.20% on average over the next years. This is quite bad
  • Based on estimates for the next years, HRZN will show a very negative growth in Revenue. The Revenue will decrease by -12.79% on average per year.
EPS Next Y-26.03%
EPS Next 2Y-13.42%
EPS Next 3Y-12.2%
EPS Next 5YN/A
Revenue Next Year4.9%
Revenue Next 2Y13.37%
Revenue Next 3Y-12.79%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HRZN Yearly Revenue VS EstimatesHRZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HRZN Yearly EPS VS EstimatesHRZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. HRZN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 3.73, which indicates a rather cheap valuation of HRZN.
  • HRZN's Price/Earnings ratio is rather cheap when compared to the industry. HRZN is cheaper than 91.67% of the companies in the same industry.
  • HRZN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.42.
  • Based on the Price/Forward Earnings ratio of 5.04, the valuation of HRZN can be described as very cheap.
  • HRZN's Price/Forward Earnings ratio is rather cheap when compared to the industry. HRZN is cheaper than 93.33% of the companies in the same industry.
  • HRZN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.73
Fwd PE 5.04
HRZN Price Earnings VS Forward Price EarningsHRZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, HRZN is valued cheaper than 89.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.28
EV/EBITDA N/A
HRZN Per share dataHRZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as HRZN's earnings are expected to decrease with -12.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.42%
EPS Next 3Y-12.2%

5

5. HRZN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 17.87%, HRZN is a good candidate for dividend investing.
  • The stock price of HRZN dropped by -41.65% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 6.51, HRZN pays a better dividend. On top of this HRZN pays more dividend than 90.42% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, HRZN pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.87%

5.2 History

  • The dividend of HRZN has a limited annual growth rate of 0.33%.
  • HRZN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.33%
Div Incr Years0
Div Non Decr Years0
HRZN Yearly Dividends per shareHRZN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • The earnings of HRZN are negative and hence is the payout ratio. HRZN will probably not be able to sustain this dividend level.
DP-1995.26%
EPS Next 2Y-13.42%
EPS Next 3Y-12.2%
HRZN Yearly Income VS Free CF VS DividendHRZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

HRZN Fundamentals: All Metrics, Ratios and Statistics

HORIZON TECHNOLOGY FINANCE C

NASDAQ:HRZN (4/24/2026, 8:00:01 PM)

After market: 3.94 +0.06 (+1.55%)

3.88

-0.15 (-3.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners8.99%
Inst Owner Change1.07%
Ins Owners1.1%
Ins Owner Change24.28%
Market Cap185.46M
Revenue(TTM)51.77M
Net Income(TTM)-2.66M
Analysts74.55
Price Target5.61 (44.59%)
Short Float %10.05%
Short Ratio4.45
Dividend
Industry RankSector Rank
Dividend Yield 17.87%
Yearly Dividend1.24
Dividend Growth(5Y)0.33%
DP-1995.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-18
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.65%
Min EPS beat(2)-39.15%
Max EPS beat(2)9.85%
EPS beat(4)1
Avg EPS beat(4)-12.33%
Min EPS beat(4)-39.15%
Max EPS beat(4)9.85%
EPS beat(8)1
Avg EPS beat(8)-10.24%
EPS beat(12)4
Avg EPS beat(12)-1.08%
EPS beat(16)7
Avg EPS beat(16)-0.3%
Revenue beat(2)1
Avg Revenue beat(2)-6.47%
Min Revenue beat(2)-20.18%
Max Revenue beat(2)7.24%
Revenue beat(4)1
Avg Revenue beat(4)-6.11%
Min Revenue beat(4)-20.18%
Max Revenue beat(4)7.24%
Revenue beat(8)1
Avg Revenue beat(8)-5.54%
Revenue beat(12)4
Avg Revenue beat(12)-2.75%
Revenue beat(16)5
Avg Revenue beat(16)-5.59%
PT rev (1m)-19.12%
PT rev (3m)-19.51%
EPS NQ rev (1m)3.65%
EPS NQ rev (3m)-23.36%
EPS NY rev (1m)-25.19%
EPS NY rev (3m)-27.95%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-11.69%
Revenue NY rev (1m)-3.81%
Revenue NY rev (3m)-5.02%
Valuation
Industry RankSector Rank
PE 3.73
Fwd PE 5.04
P/S 3.58
P/FCF 3.28
P/OCF 3.28
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)1.04
EY26.8%
EPS(NY)0.77
Fwd EY19.83%
FCF(TTM)1.18
FCFY30.53%
OCF(TTM)1.18
OCFY30.53%
SpS1.08
BVpS6.66
TBVpS6.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.4868 (221.82%)
Profitability
Industry RankSector Rank
ROA -0.33%
ROE -0.84%
ROCE 0.18%
ROIC 0.14%
ROICexc 0.17%
ROICexgc 0.18%
OM 2.37%
PM (TTM) N/A
GM 6.12%
FCFM 109.39%
ROA(3y)-1.05%
ROA(5y)1%
ROE(3y)-2.61%
ROE(5y)2.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-58.3%
ROICexgc growth 5Y-35.06%
ROICexc growth 3Y-58.47%
ROICexc growth 5Y-35.2%
OM growth 3Y-58.91%
OM growth 5Y-35.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.81%
GM growth 5Y-24.29%
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 8.35
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z -0.07
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.8%
EPS 3Y-10.28%
EPS 5Y-2.98%
EPS Q2Q%-33.33%
EPS Next Y-26.03%
EPS Next 2Y-13.42%
EPS Next 3Y-12.2%
EPS Next 5YN/A
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-6.9%
Revenue growth 5Y10.34%
Sales Q2Q%-12.23%
Revenue Next Year4.9%
Revenue Next 2Y13.37%
Revenue Next 3Y-12.79%
Revenue Next 5YN/A
EBIT growth 1Y129.46%
EBIT growth 3Y-61.75%
EBIT growth 5Y-28.59%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1338.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1338.38%
OCF growth 3YN/A
OCF growth 5YN/A

HORIZON TECHNOLOGY FINANCE C / HRZN Fundamental Analysis FAQ

What is the fundamental rating for HRZN stock?

ChartMill assigns a fundamental rating of 3 / 10 to HRZN.


Can you provide the valuation status for HORIZON TECHNOLOGY FINANCE C?

ChartMill assigns a valuation rating of 6 / 10 to HORIZON TECHNOLOGY FINANCE C (HRZN). This can be considered as Fairly Valued.


What is the profitability of HRZN stock?

HORIZON TECHNOLOGY FINANCE C (HRZN) has a profitability rating of 1 / 10.


What is the financial health of HORIZON TECHNOLOGY FINANCE C (HRZN) stock?

The financial health rating of HORIZON TECHNOLOGY FINANCE C (HRZN) is 3 / 10.


How sustainable is the dividend of HORIZON TECHNOLOGY FINANCE C (HRZN) stock?

The dividend rating of HORIZON TECHNOLOGY FINANCE C (HRZN) is 5 / 10 and the dividend payout ratio is -1995.26%.